{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:48:39Z","timestamp":1776329319289,"version":"3.50.1"},"reference-count":29,"publisher":"Universidad Nacional de C\u00f3rdoba","issue":"3","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Fac Cien Med Univ Nac Cordoba"],"abstract":"<jats:p>Introducci\u00f3n: La hidradenitis supurativa (HS) es una enfermedad cr\u00f3nica e inflamatoria que afecta principalmente \u00e1reas intertriginosas de la piel, causando lesiones dolorosas y cicatrices. La fisiopatogenia sigue siendo parcialmente desconocida, y la enfermedad se presenta con retrasos en su diagn\u00f3stico, lo que afecta la calidad de vida de los pacientes.\nObjetivos: El objetivo de este estudio fue determinar la prevalencia de la HS en una poblaci\u00f3n hospitalaria, describir sus caracter\u00edsticas cl\u00ednicas y ecogr\u00e1ficas m\u00e1s relevantes, y evaluar los tratamientos utilizados y sus respuestas terap\u00e9uticas.\nMetodolog\u00eda: Se realiz\u00f3 un estudio transversal basado en los registros de historias cl\u00ednicas de pacientes diagnosticados con HS en el Hospital Universitario Austral entre 2000 y 2024. Se recopilaron datos sobre comorbilidades, manifestaciones cl\u00ednicas, hallazgos ecogr\u00e1ficos, estadio de la enfermedad seg\u00fan Hurley modificado, tratamientos y respuesta terap\u00e9utica.\nResultados: Se analizaron 205 pacientes, con una edad media de diagn\u00f3stico de 30 a\u00f1os, siendo el 64,9% mujeres. Las \u00e1reas m\u00e1s comprometidas fueron axilas (74,6%), regi\u00f3n inguinal (34,1%) y gl\u00fatea (13,7%). Las comorbilidades m\u00e1s frecuentes fueron obesidad (26,3%) y tabaquismo (19,5%). Las \u00e1reas m\u00e1s comprometidas fueron pliegue axilar (74,6%) e inguinal (34,1%). La mayor\u00eda presento un estadio Hurley I (14%).\nConclusi\u00f3n: La HS es una enfermedad cr\u00f3nica que afecta significativamente la calidad de vida. El diagn\u00f3stico temprano es clave para un tratamiento eficaz. Este estudio aporta informaci\u00f3n valiosa sobre la prevalencia, caracter\u00edsticas cl\u00ednicas y ecogr\u00e1ficas de la enfermedad, lo que puede mejorar el manejo de los pacientes.<\/jats:p>","DOI":"10.31053\/1853.0605.v82.n3.48509","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:20:04Z","timestamp":1759170004000},"page":"599-614","source":"Crossref","is-referenced-by-count":0,"title":["Hidradenitis supurativa","Hidradenite supurativa","Hidradenitis suppurativa"],"prefix":"10.31053","volume":"82","author":[{"given":"L\u00eda Salom\u00e9","family":"Abeledo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Guthmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Caram\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Busso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12333","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mart\u00ednez Pizarro S. Suppurative hidradenitis. Rev Esp Salud Publica. 2020;94: e1-e3.","DOI":"10.4321\/S1135-57272020000100028"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Reyes-Baraona F, Herane MI, Wortsman X, Figueroa A, Garc\u00eda-Huidobro I, Giesen L, Kolbach M, Molina MT, Mu\u00f1oz L, Saavedra D, Silva-Feistner M. Gu\u00eda cl\u00ednica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo. Rev. m\u00e9d. Chile. 2021; 149(11): 1620-1635. doi. 10.4067\/S0034-98872021001101620.","DOI":"10.4067\/S0034-98872021001101620"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Melgosa Ramos FJ, Garc\u00eda Ru\u00edz R, Aguado V\u00e1zquez A, Est\u00e9banez Corrales A, D\u00edaz Corpas T, Mateu Puchades A. Determinant factors of disease severity for patients with hidradenitis suppurativa evaluated in a spanish hospital over a 5-year period. Actas Dermosifiliogr. 2025 Jan;116(1): 87-90. doi: 10.1016\/j.ad.2023.10.051.","DOI":"10.1016\/j.ad.2023.10.051"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021; 35(1):50-61. doi: 10.1111\/jdv.16677.","DOI":"10.1111\/jdv.16677"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Pandey A. Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives. Ann Med Surg (Lond). 2024 Jul 1;86(9): 5304-5313. doi: 10.1097\/MS9.0000000000002345.","DOI":"10.1097\/MS9.0000000000002345"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Melgosa Ramos FJ, Garc\u00eda-Ruiz R, Mateu Puchades A, Martorell A. [art\u00edculo traducido]. Can we improve prognosis in hidradenitis suppurativa? Identifying patients in the window of opportunity. Actas Dermosifiliogr. 2024; 115(2): T213-214. doi: 10.1016\/j.ad.2023.11.012.","DOI":"10.1016\/j.ad.2023.11.012"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Cabete J, Apar\u00edcio Martins I. Recomenda\u00e7\u00f5es na abordagem do doente com hidradenite supurativa. Acta Med Port. 2023; 36(2): 133-139. doi: 10.20344\/amp.18916.","DOI":"10.20344\/amp.18916"},{"key":"ref7","unstructured":"8. Sociedad Argentina de Dermatolog\u00eda. Grupo de trabajo de Hidradenitis Supurativa. Greco C, Lavieri A, Bittar M, Diaz Alfaro R, Fagre S, Fern\u00e1ndez Bussy S, Gato R, Gomez Zanni F, Kuyumllian S, L\u00f3pez Gamboa M, Maiolino V, Marini M, Pelizzari M, Raco C, Santiago G, Sehtman A, Vera Morandini MF. Consenso Nacional Hidradenitis Supurativa. Hu\u00eda de tratamiento. Actualizaci\u00f3n 2024 [Internet]. Sociedad Argentina de Dermatolog\u00eda. 2024; [citado 2025 Abr 1]. Disponible en: https:\/\/sad.org.ar\/wp-content\/uploads\/2024\/10\/CONSENSO-NACIONAL-HIDRADENITIS-SUPURATIVA-2024-GFF.pdf"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Magalh\u00e3es RF, Rivitti-Machado MC, Duarte GV, Souto R, Nunes DH, Chaves M, Hirata SH, Ramos AMC. Consensus on the treatment of hidradenitis suppurativa. Brazilian Society of Dermatology. An Bras Dermatol. 2019; 94(2 Suppl 1): 7-19. doi: 10.1590\/abd1806-4841.20198607.","DOI":"10.1590\/abd1806-4841.20198607"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76-90. doi: 10.1016\/j.jaad.2019.02.067.","DOI":"10.1016\/j.jaad.2019.02.067"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y. Approach to the management of patients with hidradenitis suppurativa: A consensus document. J Cutan Med Surg. 2017; 21(6): 513-524. doi: 10.1177\/1203475417716117.","DOI":"10.1177\/1203475417716117"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. \u015awierczewska Z, Lewandowski M, Surowiecka A, Bara\u0144ska-Rybak W. Microbiome in hidradenitis suppurativa - what we know and where we are heading. Int J Mol Sci. 2022; 23(19):11280. doi: 10.3390\/ijms231911280.","DOI":"10.3390\/ijms231911280"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Guerrero Centeno JA, Della Giovanna PS. Estudio de la prevalencia del s\u00edndrome metab\u00f3lico en pacientes con hidradenitis supurativa: Estudio retrospectivo de los \u00faltimos 2 a\u00f1os en el Hospital Alejandro Posadas. Dermatolog\u00eda Argentina. 2020; 26 (1): 17-22. doi: 10.47196\/da.v26i1.2062","DOI":"10.47196\/da.v26i1.2062"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Prens LM, Bouwman K, Troelstra LD, Prens EP, Alizadeh BZ, Horv\u00e1th B. New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities. Br J Dermatol. 2022; 186(5): 814-822. doi: 10.1111\/bjd.20954.","DOI":"10.1111\/bjd.20954"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Garc\u00eda-Mart\u00ednez FJ, Pascual JC, L\u00f3pez-Mart\u00edn I, Pereyra-Rodr\u00edguez JJ, Martorell Calatayud A, Salgado-Boquete L, Labandeira-Garc\u00eda J. Actualizaci\u00f3n en hidrosadenitis supurativa en Atenci\u00f3n Primaria. Semergen. 2017; 43(1): 34-42. doi: 10.1016\/j.semerg.2015.12.005.","DOI":"10.1016\/j.semerg.2015.12.005"},{"key":"ref15","unstructured":"16. Sociedad Argentina de Dermatolog\u00eda. Grupo de Trabajo de Enfermedades Autoinflamatorias e Hidradenitis Supurativa. Consenso Nacional. Hidradenitis Supurativa. Gu\u00eda de Tratamiento 2019. Sociedad Argentina de Dermatolog\u00eda. 2019; 1(1). Disponible en: https:\/\/www.google.com\/url?sa=t&source=web&rct=j&opi=89978449&url=https:\/\/sad.org.ar\/wp-content\/uploads\/2020\/01\/Consenso-Hidradenitis-Supurativa-2019-14112019_Engl.pdf&ved=2ahUKEwjT_L6V_t2PAxVSs5UCHZTQMfIQFnoECBcQAQ&usg=AOvVaw2XWtIzeg5gNLqogfZc92l_"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Zimman S, Comparatore MV, Vulcano AF, Absi ML, Mazzuoccolo LD. Hidradenitis supurativa: una aproximaci\u00f3n a su prevalencia, caracter\u00edsticas cl\u00ednicas, comorbilidades y tiempo al diagn\u00f3stico, en un hospital universitario de Buenos Aires, Argentina. Actas Dermosifiliogr. 2019; 110(4):297-302. doi: 10.1016\/j.ad.2019.01.004.","DOI":"10.1016\/j.ad.2019.01.004"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Gomes Madeira C, Ramos C, Monteiro Ferreira M. Underdiagnosis of Hidradenitis Suppurativa and the Challenge of Associated Chronic Morbidity. Acta Med Port. 2023; 36(5):373. doi: 10.20344\/amp.19833.","DOI":"10.20344\/amp.19833"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Jalenques I, Ciortianu L, Pereira B, D'Incan M, Lauron S, Rondepierre F. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(2): 542-553. doi: 10.1016\/j.jaad.2020.03.041.","DOI":"10.1016\/j.jaad.2020.03.041"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Ravn J\u00f8rgensen AH, Yao Y, Thomsen SF, Christian Ring H. M\u00e9todos referidos por los pacientes para aliviar el dolor asociado a la hidradenitis supurativa. Actas Dermosifiliogr. 2021; 112(2): 153-158. doi: 10.1016\/j.ad.2020.08.011.","DOI":"10.1016\/j.ad.2020.08.011"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Barboza-Guadagnini L, Podlipnik S, Fuertes I, Morgado-Carrasco D, Bassas-Vila J. Pain and Late-Onset of Hidradenitis Suppurativa Can Have a Negative Influence on Occupational Status and Educational Level. A Cross-Sectional Study. Actas Dermosifiliogr. 2023 Jan;114(1):1-8. doi: 10.1016\/j.ad.2022.08.016.","DOI":"10.1016\/j.ad.2022.08.016"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Go\u00f1i-Navarro A, Moll\u00e1-Roig P, de la Fuente-Meira S, Campos R\u00f3denas R. Complejidad biopsicosocial en pacientes con hidradenitis supurativa: un estudio piloto de psicodermatolog\u00eda. Actas Dermosifiliogr. 2023; 114(3) :271-273. doi: 10.1016\/j.ad.2021.12.017.","DOI":"10.1016\/j.ad.2021.12.017"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis. Australas J Dermatol. 2020 Feb;61(1):e28-e33. doi: 10.1111\/ajd.13110. Epub 2019 Jul 1. PMID: 31261440.","DOI":"10.1111\/ajd.13110"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Tannenbaum R, Strunk A, Garg A. Association between hidradenitis suppurativa and lymphoma. JAMA Dermatol. 2019; 155(5): 624-625. doi: 10.1001\/jamadermatol.2018.5230.","DOI":"10.1001\/jamadermatol.2018.5230"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Garc\u00eda-Mart\u00ednez FJ, Pascual JC, L\u00f3pez-Mart\u00edn I, Pereyra-Rodr\u00edguez JJ, Martorell Calatayud A, Salgado-Boquete L, Labandeira-Garc\u00eda J. Actualizaci\u00f3n en hidrosadenitis supurativa en Atenci\u00f3n Primaria. Semergen. 2017; 43(1):34-42. doi: 10.1016\/j.semerg.2015.12.005.","DOI":"10.1016\/j.semerg.2015.12.005"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Shih T, Seivright JR, McKenzie SA, Harview CL, Truong AK, Shi VY, Bennett RG, Hsiao JL. Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis. Int J Womens Dermatol. 2021; 7(5): 672-674. doi: 10.1016\/j.ijwd.2021.07.003.","DOI":"10.1016\/j.ijwd.2021.07.003"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Garc\u00eda-Mart\u00ednez FJ, Pascual JC, L\u00f3pez-Mart\u00edn I, Pereyra-Rodr\u00edguez JJ, Martorell Calatayud A, Salgado-Boquete L, Labandeira-Garc\u00eda J. Actualizaci\u00f3n en hidrosadenitis supurativa en Atenci\u00f3n Primaria. Semergen. 2017;43(1) :34-42. doi: 10.1016\/j.semerg.2015.12.005.","DOI":"10.1016\/j.semerg.2015.12.005"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Martorell A, Garc\u00eda FJ, Jim\u00e9nez-Gallo D, Pascual JC, Pereyra-Rodr\u00edguez J, Salgado L, Villarrasa E. Actualizaci\u00f3n en hidradenitis supurativa (ii): aspectos terap\u00e9uticos. Actas Dermosifiliogr. 2015; 106(9): 716-724. doi: 10.1016\/j.ad.2015.06.005.","DOI":"10.1016\/j.ad.2015.06.005"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Mansilla-Polo M, Escutia-Mu\u00f1oz B, Botella-Estrada R. Narrative review and update on biologic and small molecule drugs for hidradenitis suppurativa: An entity with a promising future. Actas Dermosifiliogr. 2023; 114(9): 772-783. doi: 10.1016\/j.ad.2023.05.015.","DOI":"10.1016\/j.ad.2023.05.015"}],"container-title":["Revista de la Facultad de Ciencias M\u00e9dicas de C\u00f3rdoba"],"original-title":[],"link":[{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/48509\/50406","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/48509\/50407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/48509\/50407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:43:52Z","timestamp":1759506232000},"score":1,"resource":{"primary":{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/view\/48509"}},"subtitle":["caracter\u00edsticas epidemiol\u00f3gicas m\u00e1s relevantes de una enfermedad subdiagnosticada. Estudio de corte transversal","caracter\u00edsticas epidemiol\u00f3gicas mais relevantes de uma doen\u00e7a subdiagnosticada. Estudo transversal","most relevant epidemiological characteristics of an underdiagnosed disease. A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,29]]}},"URL":"https:\/\/doi.org\/10.31053\/1853.0605.v82.n3.48509","relation":{},"ISSN":["1853-0605","0014-6722"],"issn-type":[{"value":"1853-0605","type":"electronic"},{"value":"0014-6722","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}